Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. MRNA
MRNA logo

MRNA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MRNA News

Moderna Shares Rise 2.51% Ahead of Earnings Report

1d agoNASDAQ.COM

Moderna's Optimistic Vaccine Pipeline Sparks Investor Interest

1d agoFool

Arbutus and Moderna Reach $2.25 Billion Settlement

18h agostocktwits

Biotech Stocks Outperform S&P 500 in H1 2026

1d agoFool

Biotech Companies Reach Critical Turning Point

1d agoNASDAQ.COM

Analysis of RSP ETF's 52-Week Price Fluctuations

1d agoNASDAQ.COM

Moderna Stock Surges 10% to Yearly High Amid FDA Vote

4d agoFool

Moderna's Flu Vaccine Gains FDA Advisory Panel Support

4d agoNASDAQ.COM

Investors Weigh Moderna Against Recursion in Biotech Landscape

4d agoFool

Future Prospects of Moderna and Recursion

4d agoNASDAQ.COM

PANW, AAL, MRNA Stocks Surge Amid Optimism

6d agostocktwits

Moderna's Expanding Pipeline Sparks Investor Interest

6d agoCNBC

Moderna's Evolving Pipeline Sparks Long-Term Investment Interest

6d agoNewsfilter

FDA Revives Advisory Committee Meetings for Drug Approvals

6d agoseekingalpha

Moderna's Stock Surges Nearly 150% Amid Regulatory Progress

Jun 30 2026Fool

Moderna's mRNA Flu Vaccine Gains FDA Support

Jun 30 2026NASDAQ.COM